T2 Biosystems, Inc.
(NASDAQ : TTOO)

( )
TTOO PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc. -1.54%74.761.0%$1946.65m
AMGNAmgen, Inc. -2.76%202.731.3%$903.34m
REGNRegeneron Pharmaceuticals, Inc. 3.23%488.292.6%$833.80m
BIIBBiogen, Inc. 0.08%316.381.5%$759.21m
VRTXVertex Pharmaceuticals, Inc. 2.60%237.951.9%$588.30m
MRNAModerna, Inc. -1.74%29.950.0%$535.64m
ILMNIllumina, Inc. -1.13%273.123.5%$472.24m
ALXNAlexion Pharmaceuticals, Inc. 2.90%89.792.0%$286.04m
AAgilent Technologies, Inc. -1.50%71.581.6%$228.47m
EXASEXACT Sciences Corp. -0.74%58.0021.0%$194.38m
INCYIncyte Corp. 1.47%73.232.5%$176.59m
SGENSeattle Genetics, Inc. 0.08%115.386.1%$169.50m
BMRNBioMarin Pharmaceutical, Inc. 2.44%84.504.3%$166.37m
NVAXNovavax, Inc. -5.04%13.58114.7%$124.83m
ALNYAlnylam Pharmaceuticals, Inc. 0.02%108.858.7%$102.43m

Company Profile

T2 Biosystems, Inc. engages in the development of proprietary technology platform. It offers the T2 Magnetic Resonance technology, which enables rapid detection of pathogens, biomarkers and other abnormalities in a variety of unpurified patient sample types. It products include T2Bacteria Panel, T2Candida Panel, T2Dx Instrument, AND T2MR Technology. The company was founded by Michael J. Cima, Robert S. Langer Jr., Tyler Jacks, Lee Josephson, W. David Lee, and Ralph Weissleder on April 27, 2006 and is headquartered in Lexington, MA.